AB Foods Backs Fiscal Year 2023 Views After 1st Half Sales Rose, Although Profit Fell
By Michael Susin
Associated British Foods PLC said Tuesday that adjusted operating profit for the first half of fiscal 2023 fell, but backed its full-year guidance amid robust sales growth and less volatile inflation, and raised its dividend payout.
The British conglomerate posted an adjusted operating profit----which strips out exceptional and other one-off items--for the 24 weeks ended March 4 of 684 million pounds ($854 million) compared with GBP706 million for the year-earlier period.
The FTSE 100 listed company's revenue came in at GBP9.56 billion from GBP7.88 billion for the year-earlier period.
Primark sales rose to GBP4.23 billion from GBP3.54 billion, in line with guidance of around GBP4.2 billion.
The board declared an interim dividend of 14.2 pence a share, up from 13.8 pence declared a year ago.
The British conglomerate backed its full-year targets of adjusted operating profit and adjusted earnings per share to be in line with previous financial year. Adjusted operating profit for its food businesses is expected to be modestly ahead of last year, it added.
Primark expects to report 2023 like-for-like sales growth in the second half, although it is anticipated to moderate from the rate of growth reported in the first half, while adjusted operating margin is anticipated to be around 8.3%.
Write to Michael Susin at michael.susin@wsj.com
(END) Dow Jones Newswires
April 25, 2023 02:37 ET (06:37 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
Markets Brief: Stocks Are Starting to Look Cheap Again
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year
-
Snap Earnings: Advertising Growth and Snapchat+ Drive Monetization
-
STMicro Earnings: We Still See an Attractive Margin of Safety Despite a Poor First-Half Forecast
-
Alphabet Shares Surge on Strong Earnings, Dividend Surprise
-
Microsoft Earnings: Firm Beats Forecasts on Strong AI and Cloud Demand
-
PG&E Earnings: Near-Term Regulatory Certainty Supports Industry-Leading Earnings Growth